Role of diet and nutritional management in non-alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue S4, 2013, Pages 81-87

  Fan, Jian Gao ^a   Cao, Hai Xia ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Diet; Fatty liver; NAFLD NASH; Nutrition; Obesity

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; CHOLINE; FAT; FRUCTOSE; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PROBIOTIC AGENT; PROTEIN; SATURATED FATTY ACID; SOYBEAN PROTEIN; TRACE ELEMENT; TRANS FATTY ACID;

ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR MODIFICATION; BEVERAGE; CALORIC RESTRICTION; COFFEE; COMORBIDITY; DIET SUPPLEMENTATION; DISEASE COURSE; EXERCISE; FEEDING BEHAVIOR; FIBER; HEPATITIS; HUMAN; INCIDENCE; INTRAABDOMINAL FAT; LIPID LIVER LEVEL; LIPID STORAGE; LIVER NECROSIS; LOW CALORY DIET; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NUTRITIONAL SUPPORT; OBESITY; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; TEA; WEIGHT REDUCTION; WHEY;

DIET; FATTY LIVER; NAFLD/NASH; NUTRITION; OBESITY;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DIET, REDUCING; DISEASE PROGRESSION; ENERGY INTAKE; FATTY LIVER; HUMANS; LIFE STYLE; LIVER CIRRHOSIS; METABOLIC SYNDROME X; OBESITY; RISK; WEIGHT LOSS;

EID: 84897632457     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12244     Document Type: Article

References (43)

1. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
2. Fan JG, Jia JD, Li YM etal. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010. (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J. Dig. Dis. 2011; 12: 38-44.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J. Hepatol. 2009; 50: 204-210.
4. Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 2012; 15: 468-473.
5. Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 2012; 46: 457-467.
6. McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic Fatty liver disease. J. Acad. Nutr. Diet. 2012; 112: 401-409.
7. de Wit NJ, Afman LA, Mensink M, Müller M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. J. Hepatol. 2012; 57: 1370-1373.
8. Strychar I. Diet in the management of weight loss. CMAJ 2006; 174: 56-63.
9. Sacks FM, Bray GA, Carey VJ etal. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 2009; 360: 859-873.
10. Moyer VA; U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2012; 157: 373-378.
11. Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J. Hepatol. 2012; 56: 255-266.
12. Maersk M, Belza A, Stodkilde-Jorgensen H etal. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am. J. Clin. Nutr. 2012; 95: 283-289.
13. Abdelmalek MF, Suzuki A, Guy C etal. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51: 1961-1971.
14. Stanhope KL, Schwarz JM, Keim NL etal. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009; 119: 1322-1334.
15. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J. Nutr. Biochem. 2012; 23: 203-208.
16. Ferolla SM, Ferrari TC, Lima ML etal. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo) 2013; 68: 11-17.
17. Savard C, Tartaglione EV, Kuver R etal. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2013; 57: 81-92.
18. Min HK, Kapoor A, Fuchs M etal. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012; 15: 665-674.
19. Parker HM, Johnson NA, Burdon CA etal. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Hepatol. 2012; 56: 944-951.
20. Santoro N, Savoye M, Kim G etal. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake. PLoS ONE 2012; 7: e37827.
21. Bjermo H, Iggman D, Kullberg J etal. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr. 2012; 95: 1003-1012.
22. Bortolotti M, Kreis R, Debard C etal. High protein intake reduces intrahepatocellular lipid deposition in humans. Am. J. Clin. Nutr. 2009; 90: 1002-1010.
23. Bortolotti M, Maiolo E, Corazza M etal. Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clin. Nutr. 2011; 30: 494-498.
24. Tovar AR, Torres N. The role of dietary protein on lipotoxicity. Biochim. Biophys. Acta 2010; 1801: 367-371.
25. Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr. Opin. Gastroenterol. 2012; 28: 159-165.
26. Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr. Rev. 2012; 70: 41-56.
27. Birerdinc A, Stepanova M, Pawloski L, Younossi ZM. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2012; 35: 76-82.
28. Molloy JW, Calcagno CJ, Williams CD etal. Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012; 55: 429-436.
29. Musso G, Cassader M, Rosina F, Gambino R. Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. Diabetologia 2012; 55: 885-904.
30. Rodríguez-Hernández H, Cervantes-Huerta M, Rodríguez-Moran M, Guerrero-Romero F. Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. Ann. Hepatol. 2011; 10: 486-492.
31. Grønbæk H, Lange A, Birkebæk NH etal. Effect of a 10-week weight loss camp on fatty liver disease and insulin sensitivity in obese Danish children. J. Pediatr. Gastroenterol. Nutr. 2012; 54: 223-228.
32. Sevastianova K, Santos A, Kotronen A etal. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am. J. Clin. Nutr. 2012; 96: 727-734.
33. Goran MI, Walker R, Allayee H. Genetic-related and carbohydrate-related factors affecting liver fat accumulation. Curr. Opin. Clin. Nutr. Metab. Care 2012; 15: 392-396.
34. Schugar RC, Crawford PA. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr. Opin. Clin. Nutr. Metab. Care 2012; 15: 374-380.
35. Nobili V, Bedogni G, Alisi A etal. Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch. Dis. Child. 2011; 96: 350-353.
36. Oliveira LP, de Jesus RP, Boulhosa RS etal. Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial. World J. Gastroenterol. 2012; 18: 2203-2211.
37. Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2012; 32: 701-711.
38. Dunn W, Sanyal AJ, Brunt EM etal. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). J. Hepatol. 2012; 57: 384-391.
39. Lavine JE, Schwimmer JB, Van Natta ML etal. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA 2011; 305: 1659-1668.
40. Klein EA, Thompson IM Jr, Tangen CM etal. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306: 1549-1556.
41. Iacono A, Raso GM, Canani RB, Calignano A, Meli R. Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms. J. Nutr. Biochem. 2011; 22: 699-711.
42. Aller R, De Luis DA, Izaola O etal. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur. Rev. Med. Pharmacol. Sci. 2011; 15: 1090-1095.
43. Malaguarnera M, Vacante M, Antic T etal. Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig. Dis. Sci. 2012; 57: 545-553.